Lv7
5000 积分 2022-12-07 加入
Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer
12天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
12天前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
18天前
已完结
Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
19天前
已完结
Mining Whole-liver Information with Deep Learning for Preoperatively Predicting HCC Recurrence-free Survival *
19天前
已完结
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization
20天前
已完结
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
25天前
已完结
Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial
1个月前
已完结
Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
1个月前
已完结
Therapeutic effect of Jianpi Liqi Fang combined with transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and spleen deficiency syndrome
1个月前
已完结
器官移植受者新型冠状病毒感染入院治疗药物使用建议(2023版)
2年前
已驳回
非靶向和靶向代谢组学在药物靶点发现中的应用
2年前
已采纳
皖公网安备34019202002308
